Sylvia M Frydman Selected Research

Casein Kinase Idelta

1/2020

Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia M Frydman Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 11/2019
1	Neoplasm Metastasis (Metastasis) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Adenocarcinoma 01/2020

Drug/Important Bio-Agent (IBA)

1	CateninsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Gemcitabine FDA Link 01/2020
1	Casein Kinase IdeltaIBA 01/2020
1	SR-3029IBA 01/2020
1	Deoxycytidine KinaseIBA 01/2020
1	ChromatinIBA 11/2019